Evidence map›Paper›PMID 35867709›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2022

Ischemic damage to every segment of the oxidative phosphorylation cascade elevates ETC driving force and ROS production in cardiac mitochondria.

Sarah Kuzmiak-Glancy, Brian Glancy, Matthew W Kay

Open access · hybridAbstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Sarah Kuzmiak-GlancyDepartment of Kinesiology, School of Public Health, University of Maryland, College Park, Maryland.ORCID 0000-0002-2196-6643
Brian GlancyLaboratory of Muscle Energetics, National Heart, Lung, and Blood Institute and National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland.ORCID 0000-0002-8571-244X
Matthew W KayDepartment of Biomedical Engineering, The George Washington University, Washington, District of Columbia.ORCID 0000-0003-2756-5055
George Washington University · USNational Institutes of Health · USUniversity of Maryland, College Park · US

Funding

Development and Regulation of the Muscle Mitochondrial ReticulumZIAHL006221 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI GLANCY, BRIAN · 2017 to 2025
$14.7M
Scalable platform for optimizing human cardiac tissue engineering via optical pacing and on-demand oxygenationR01HL144157 · NHLBI · GEORGE WASHINGTON UNIVERSITY · PI ENTCHEVA, EMILIA, KAY, MATTHEW W. · 2019 to 2022
$2.8M
Hypothalamic neuron activation to blunt myocardial remodeling during chronic sleep apneaR01HL146169 · NHLBI · GEORGE WASHINGTON UNIVERSITY · PI KAY, MATTHEW W. · 2019 to 2022
$2.6M
Novel Mechanisms that Restore Cardiac Parasympathetic Activity Limits Arrhythmias and Cardiac Dysfunction After Myocardial InfarctionR01HL147279 · NHLBI · GEORGE WASHINGTON UNIVERSITY · PI KAY, MATTHEW W., MENDELOWITZ, DAVID · 2020 to 2023
$2.3M
HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL146169HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL147279NHLBI NIH HHS R01 HL144157NHLBI NIH HHS R01 HL146169NHLBI NIH HHS R01 HL147279
6 · The paper itself

Abstract

Myocardial ischemia has long-lasting negative impacts on cardiomyocyte mitochondrial ATP production. However, the location(s) of damage to the oxidative phosphorylation pathway responsible for altered mitochondrial function is unclear. Mitochondrial reactive oxygen species (ROS) production increases following ischemia, but the specific factors controlling this increase are unknown. To determine how ischemia affects the mitochondrial energy conversion cascade and ROS production, mitochondrial driving forces [redox potential and membrane potential (ΔΨ)] were measured at resting, intermediate, and maximal respiration rates in mitochondria isolated from rat hearts after 60 min of control flow (control) or no-flow ischemia (ischemia). The effective activities of the dehydrogenase enzymes, the electron transport chain (ETC), and ATP synthesis and transport were computed using the driving forces and flux. Ischemia lowered maximal mitochondrial respiration rates and diminished the responsiveness of respiration to both redox potential and ΔΨ. Ischemia decreased the activities of every component of the oxidative phosphorylation pathway: the dehydrogenase enzymes, the ETC, and ATP synthesis and transport. ROS production was linearly related to driving force down the ETC; however, ischemia mitochondria demonstrated a greater driving force down the ETC and higher ROS production. Overall, results indicate that ischemia ubiquitously damages the oxidative phosphorylation pathway, reduces mitochondrial sensitivity to driving forces, and augments the propensity for electrons to leak from the ETC. These findings underscore that strategies to improve mitochondrial function following ischemia must target the entire mitochondrial energy conversion cascade.

Indexed as

Myocardial IschemiaOxidative PhosphorylationAdenosine TriphosphateAnimalsIschemiaMitochondria, HeartOxidoreductasesRatsReactive Oxygen SpeciesAdenosine TriphosphateOxidoreductasesReactive Oxygen Speciescardiac ischemiametabolic controlmitochondriareactive oxygen species

Identifiers

PMID35867709
PMCPMC9448280
OpenAlexW4286587454

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.